Register
Medicines reference
Product

Enterogermina Forte

· Sanofi / Opella

1 form: suspension. In force in Georgia: 1 of 1 (human register).

Forms and doses1 of 1 in force in Georgia

Form Dose Frequency Georgia
4 billion/5 ml, Suspension No label dose in the reference yet - Georgia Yes, human
In force until 31 Mar 2027
Human (Ministry of Health, RAMA)
In the register: ენტეროგერმინა ფორტე 4 მილიარდი/5 მლ, პერორალური სუსპენზია
№ რ-040740
Verified on: 16 Oct 2026
Details: pack, label wording, sources, registration

Enterogermina Forte 4 billion/5 ml, Suspension

oral suspension, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Off-label in dogs: human Bacillus clausii spore probiotic (4 billion spores per 5 ml vial), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea
Not rateable
No numerical score assigned
vetman assessment

Enterogermina Forte

4 billion/5 ml, oral suspension, human medicine
Assessed clinical scopeDog · Off-label in dogs: human Bacillus clausii spore probiotic (4 billion spores per 5 ml vial), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea · By mouth
Care settingVeterinary-directed adjunct under the cascade, alongside standard supportive care of diarrhoea
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-040740 · Verified on 16 Oct 2026 Off-label use
Not rateable

Not rateable for dogs or cats: these are human Bacillus clausii presentations with no authoritative veterinary dose, no target-animal safety study and no controlled clinical outcome study for the assessed diarrhoea role.

Human product identity is documented, but the veterinary evidence needed for a numerical benefit-risk score is absent.

Important safety and use flags

  • Oral presentation only: never inject the contents. Do not use with hypersensitivity to the spores or excipients.
  • Bloody diarrhoea, repeated vomiting, lethargy, fever or dehydration need veterinary assessment and supportive care; a probiotic does not treat them.
  • Veterinary safety is not established; avoid use in immunosuppressed or critically ill animals and in patients with central venous catheters.
  • No veterinary interaction study establishes timing with antibiotics; do not infer a dog or cat regimen from human instructions.
  • Human medicine with no veterinary dose; record the off-label use and the amount given.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Off-label in cats: human Bacillus clausii spore probiotic (4 billion spores per 5 ml vial), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea
Not rateable
No numerical score assigned
vetman assessment

Enterogermina Forte

4 billion/5 ml, oral suspension, human medicine
Assessed clinical scopeCat · Off-label in cats: human Bacillus clausii spore probiotic (4 billion spores per 5 ml vial), sometimes given as an adjunct in acute or antibiotic-associated diarrhoea · By mouth
Care settingVeterinary-directed adjunct under the cascade, alongside standard supportive care of diarrhoea
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, human · № რ-040740 · Verified on 16 Oct 2026 Off-label use
Not rateable

Not rateable for dogs or cats: these are human Bacillus clausii presentations with no authoritative veterinary dose, no target-animal safety study and no controlled clinical outcome study for the assessed diarrhoea role.

Human product identity is documented, but the veterinary evidence needed for a numerical benefit-risk score is absent.

Important safety and use flags

  • Oral presentation only: never inject the contents. Do not use with hypersensitivity to the spores or excipients.
  • Bloody diarrhoea, repeated vomiting, anorexia, lethargy or dehydration need veterinary assessment and supportive care; a probiotic does not treat them.
  • Veterinary safety is not established; avoid use in immunosuppressed or critically ill animals and in patients with central venous catheters.
  • No veterinary interaction study establishes timing with antibiotics; do not infer a dog or cat regimen from human instructions.
  • Human medicine with no veterinary dose; record the off-label use and the amount given.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Formulation Type
Suspension
Administration route
By mouth
Manufacturer
Sanofi / Opella · France
Registration
Georgia Yes, human
In force until 31 Mar 2027
Human (Ministry of Health, RAMA)
In the register: ენტეროგერმინა ფორტე 4 მილიარდი/5 მლ, პერორალური სუსპენზია
№ რ-040740
Verified on: 16 Oct 2026
EU No
UK No
Verified on: 16 Oct 2026
US No
Verified on: 16 Oct 2026
Controlled in Georgia
Unknown

No dose supported by a publicly verifiable source yet

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.